미용 성형 및 시술 시장 규모, 점유율, 동향 분석 보고서 : 시술 유형별, 성별, 연령층별, 지역별, 부문별 예측(2025-2033년)

Cosmetic Surgery & Procedure Market Summary

The global cosmetic surgery and procedure market size was estimated at USD 83.07 billion in 2024 and is expected to reach USD 195.87 billion by 2033, growing at a CAGR of 10.09% from 2025 to 2033. The industry is driven by a growing awareness of aesthetic treatments, spurred by social media and celebrity culture, which has led to a higher demand for procedures to enhance physical appearance.

To learn more about this report, request a free sample copy

Moreover, technological advancements, such as minimally invasive techniques, laser treatments, and injectables such as Botox and dermal fillers, have made cosmetic procedures safer and more accessible, encouraging more individuals to consider them. In addition, the increase in healthcare tourism and the availability of well-trained specialists in emerging markets also support the expansion of this market.

Global Cosmetic Surgery & Procedure Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cosmetic surgery and procedure market report based on procedure type, gender, age group, and region:

• Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
• Invasive Procedures
  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Eyelid Surgery
  • Tummy Tuck
  • Others
• Non-invasive Procedures
  • Botox Injections
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Others
• Gender Outlook (Revenue, USD Million, 2021 - 2033)
• Male
• Female
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• 13-29
• 30-54
• 55 and above
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
• 1.6. Data Validation & Publishing
• 1.7. List of Secondary Sources
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Cosmetic Surgery and Procedure Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Acceptance of Cosmetic Procedures
    • 3.2.1.2. Increasing Influence of Social Media and Changing Beauty Standards
    • 3.2.1.3. Technological Advancements and Procedure Accessibility
    • 3.2.1.4. Growing Medical Tourism and Regional Hubs
    • 3.2.1.5. Availability of Skilled Professionals and Advanced Facilities
    • 3.2.1.6. Affordability and Financing Options
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory Challenges and Safety Concerns
    • 3.2.2.2. High Procedure Costs
• 3.3. Business Environmental Tools Analysis: Cosmetic Surgery and Procedure Market
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis

Chapter 4. Cosmetic Surgery and Procedure Market: Procedure Type Estimates & Trend Analysis

• 4.1. Cosmetic Surgery and Procedure Market, By Procedure Type: Key Takeaways
• 4.2. Cosmetic Surgery and Procedure Market: Procedure Type Movement & Market Share Analysis, 2024 & 2033
• 4.3. Invasive Procedures
  • 4.3.1. Invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.2. Breast Augmentation
    • 4.3.2.1. Breast Augmentation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.3. Liposuction
    • 4.3.3.1. Liposuction Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.4. Nose Reshaping
    • 4.3.4.1. Nose Reshaping Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.5. Eyelid Surgery
    • 4.3.5.1. Eyelid Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.6. Tummy Tuck
    • 4.3.6.1. Tummy Tuck Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.3.7. Others
    • 4.3.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.4. Non-invasive Procedures
  • 4.4.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.2. Botox Injections
    • 4.4.2.1. Botox Injections Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.3. Soft Tissue Fillers
    • 4.4.3.1. Soft Tissue Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.4. Chemical Peel
    • 4.4.4.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.5. Laser hair removal
    • 4.4.5.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.6. Microdermabrasion
    • 4.4.6.1. Microdermabrasion Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.7. Others
    • 4.4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Cosmetic Surgery and Procedure Market: Gender Estimates & Trend Analysis

• 5.1. Cosmetic Surgery and Procedure Market, By Gender: Key Takeaways
• 5.2. Cosmetic Surgery and Procedure Market: Gender Movement & Market Share Analysis, 2024 & 2033
• 5.3. Male
  • 5.3.1. Male Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.4. Female
  • 5.4.1. Female Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Cosmetic Surgery and Procedure Market: Age Group Estimates & Trend Analysis

• 6.1. Cosmetic Surgery and Procedure Market, By Age Group: Key Takeaways
• 6.2. Cosmetic Surgery and Procedure Market: Age Group Movement & Market Share Analysis, 2024 & 2033
• 6.3. 13 - 29
  • 6.3.1. 13 - 29 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.4. 30 - 54
  • 6.4.1. 30 - 54 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.5. 55 and Above
  • 6.5.1. 55 and Above Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Cosmetic Surgery and Procedure Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market position analysis, 2024
• 8.4. List of Companies
  • 8.4.1. AbbVie Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Cynosure
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Evolus Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. RevanceGalderma
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Lumenis
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Solta Medical
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Syneron Candela
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Alma Laser
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Airsculpt Technologies, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. The Esthetic Clinics
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Service benchmarking
    • 8.4.10.4. Strategic initiatives